Chemical formula:
C6H7N3O
SAR:
Isoniazid is an antimycobacterial agent used primarily as a tuberculostatic.
It is an analogue of pyridoxine (vitamin B6), and its activity is related to its structural similarity to this compound.
Isoniazid inhibits the synthesis of mycolic acid, an essential component of the Mycobacterium cell wall.
The isonicotinic acid hydrazide moiety is essential for its activity.
Synthesis:
The synthesis of Isoniazid can be conducted as follows:
STEP 1: 4-Cyanopyridine is treated with sodium hypobromite, which undergoes a ring-opening reaction to yield isonicotinic acid:
4-Cyanopyridine + NaOBr → Isonicotinic acid
STEP 2: Isonicotinic acid is then reacted with hydrazine to yield Isoniazid:
Isonicotinic acid + N2H4 → Isoniazid + H2O
Mechanism of action:
Isoniazid is a prodrug that is activated by the mycobacterial enzyme KatG.
The activated compound interferes with the synthesis of mycolic acid, a crucial component of the mycobacterial cell wall, thereby inhibiting the growth of Mycobacterium tuberculosis.
Uses:
Isoniazid is used primarily for the treatment and prevention of tuberculosis (TB).
Side effects:
Side effects can include hepatotoxicity, peripheral neuropathy, hypersensitivity reactions, and gastrointestinal disturbances.